The use of temporary mechanical circulatory support (tMCS) devices and in particular the increasing use of the Impella device family has gained significant interest over the last two decades. Nowadays, its use plays a well-established key role in both the treatment of cardiogenic shock, and as a preventive and protective therapeutic option during high-risk procedures in both cardiac surgery and cardiology, such as complex percutaneous interventions (protected PCI). Thus, it is not surprising that the Impella device is more and more present in the perioperative setting and especially in patients on intensive care units. Despite the numerous advantages such as cardiac resting and hemodynamic stabilization, potential adverse events exist, which may lead to severe, but preventable complications, so that adequate education, early recognition of such events and a subsequent adequate management are crucial in patients with tMCS. This article provides an overview especially for anesthesiologists and intensivists focusing on technical basics, indications and contraindications for its use with special focus on the intra- and postoperative management. Furthermore, troubleshooting for most common complications for patients on Impella support is provided.
Keyphrases
- cardiac surgery
- end stage renal disease
- extracorporeal membrane oxygenation
- newly diagnosed
- chronic kidney disease
- ejection fraction
- intensive care unit
- healthcare
- acute kidney injury
- patients undergoing
- prognostic factors
- minimally invasive
- coronary artery disease
- acute myocardial infarction
- acute coronary syndrome
- mechanical ventilation
- patient reported outcomes
- blood pressure
- heart rate
- risk factors
- patient reported
- smoking cessation
- early onset
- climate change